Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
- 1Department of Hepatology, Humboldt University, Berlin, Germany.
- 0Department of Hepatology, Humboldt University, Berlin, Germany.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Activated signal transducer and activator of transcription 3 (STAT3) drives pancreatic cancer growth by accelerating cell cycle progression. Inhibiting STAT3 significantly reduces tumor proliferation and contributes to the malignant phenotype.
Area Of Science
- Oncology
- Molecular Biology
- Cell Biology
Background
- Signal transducer and activator of transcription 3 (STAT3) is implicated in cancer growth and malignant transformation.
- Constitutive activation of STAT3 is frequently observed in human cancers.
Purpose Of The Study
- To analyze the expression and biological significance of STAT3 in human pancreatic cancer cells.
- To investigate the role of STAT3 in pancreatic cancer proliferation and tumorigenicity.
Main Methods
- Immunohistochemistry and immunoblotting were used to assess STAT3 expression and activation.
- Dominant-negative STAT3 constructs were employed for functional inactivation in pancreatic cancer cell lines.
- Cell proliferation, colony formation, xenotransplantation, and cell cycle analysis were performed to evaluate STAT3's role.
Main Results
- Activated STAT3 is overexpressed in human pancreatic ductal carcinoma cells and cancer cell lines.
- STAT3 inactivation significantly inhibited proliferation in vitro and reduced tumor growth in vivo.
- STAT3 inhibition delayed G(1)/S-phase progression by affecting cyclin-dependent kinase 2 activity and increasing p21(WAF1) expression.
Conclusions
- Activated STAT3 promotes pancreatic cancer cell proliferation by accelerating G(1)/S-phase progression.
- STAT3 contributes to the malignant phenotype of human pancreatic cancer.
- Targeting STAT3 signaling presents a potential therapeutic strategy for pancreatic cancer.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.